Published in Healthcare Mergers, Acquisitions and Ventures Week, May 24th, 2008
"We are pleased to accept this award for our DXL(TM) technology and anticipate many new innovative products to emerge in the near future from this technology," said Jeff Morhet, CEO and Chairman of InNexus Biotechnology.
Pablo Legorreta, Chief Executive Officer of Royalty Pharma stated, "I'm pleased with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.